GeneNews Extends Term of Warrants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneNews has extended the term of certain purchase warrants to July 31, 2012.

The warrants were issued by the Canadian molecular diagnostics firm on Jan. 16, 2009 and Feb. 11, 2009, entitling holders to purchase one common share of GeneNews at an exercise price of C$.25 ($US.25) per share.

There are 1 million warrants that were set to expire on Jan. 16, 2012, and there are 1,978,065 warrants that were set to expire on Feb. 11, 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.